John R. Stuelpnagel, Director at 10x Genomics, Inc. (TXG), sold 5,000 shares at $150.18 ($751K) on 2021-10-07, disclosed to the SEC on 2021-10-12.
Open-market sale of $751k TXG by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TXG | SELL | 2023-06-07 | $549K | — | Filing → |
| TXG | SELL | 2022-01-04 | $1.5M | — | Filing → |
| TXG | SELL | 2021-12-03 | $756K | — | Filing → |